Skip to main content
Veterinary Medicines

COGLAVAX

Authorised
  • Clostridium perfringens, type A, alpha toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium perfringens, type C, beta toxoid
  • Clostridium tetani, toxoid
  • Clostridium septicum, toxoid
  • Clostridium novyi, type B, toxoid
  • Clostridium chauvoei, strain Hung 89, Inactivated

Product identification

Medicine name:
COGLAVAX
Active substance:
  • Clostridium perfringens, type A, alpha toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium perfringens, type C, beta toxoid
  • Clostridium tetani, toxoid
  • Clostridium septicum, toxoid
  • Clostridium novyi, type B, toxoid
  • Clostridium chauvoei, strain Hung 89, Inactivated
Target species:
  • Cattle
  • Rabbit (for reproduction)
  • Rabbit
  • Sheep
  • Goat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium perfringens, type A, alpha toxoid
    4.00
    international unit(s)
    /
    1.00
    unit(s)
  • Clostridium perfringens, type D, epsilon toxoid
    10.00
    international unit(s)
    /
    1.00
    unit(s)
  • Clostridium perfringens, type C, beta toxoid
    20.00
    international unit(s)
    /
    1.00
    unit(s)
  • Clostridium tetani, toxoid
    5.00
    international unit(s)
    /
    1.00
    unit(s)
  • Clostridium septicum, toxoid
    5.00
    international unit(s)
    /
    1.00
    unit(s)
  • Clostridium novyi, type B, toxoid
    7.00
    international unit(s)
    /
    1.00
    unit(s)
  • Clostridium chauvoei, strain Hung 89, Inactivated
    1.00
    100% protective dose
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • All relevant tissues
        0
        day
    • Rabbit (for reproduction)
      • All relevant tissues
        0
        day
    • Rabbit
      • All relevant tissues
        0
        day
    • Sheep
      • All relevant tissues
        0
        day
    • Goat
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB01
  • QI03AB
  • QI04AB01
  • QI08AB
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Cz Veterinaria S.A.
Responsible authority:
  • National Veterinary Medicines Agency
Authorisation number:
  • FR/V/5726681 3/1982
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 27/09/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."